SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs

Active, not recruitingOBSERVATIONAL
Enrollment

458

Participants

Timeline

Start Date

August 11, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

September 30, 2028

Conditions
Peripheral Arterial Disease
Trial Locations (1)

06510

Yale New Haven Health, New Haven

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

University of Chicago

OTHER

collaborator

Oregon Health and Science University

OTHER

collaborator

University of California, Davis

OTHER

collaborator

University of Southern California

OTHER

collaborator

Baylor College of Medicine

OTHER

collaborator

The Cleveland Clinic

OTHER

collaborator

Emory University

OTHER

collaborator

Brown University

OTHER

collaborator

Columbia University

OTHER

collaborator

University of Minnesota

OTHER

collaborator

Saint Luke's Health System

OTHER

collaborator

Abbott

INDUSTRY

collaborator

Janssen Scientific Affairs, LLC

INDUSTRY

lead

Yale University

OTHER